News & Event

Register for news & events
Loading
News background
News icon

2020

Tel Aviv Medical Center is recruiting Age related Macular Degeneration patients for a REVITALVISION clinical study

A Proof-of-Concept, Prospective, Open label, Randomized Clinical Study Evaluating RevitalVision® Therapy for Improving Best Corrected Visual Acuity (BCVA) and Contrast Sensitivity Function (CSF) in Patients Suffering from stabler Age related Macular Degeneration (AMD)

Logo of Tel Aviv medical center

Contact Us


    Talshir Medical Technologies LTD
    Hama’ayan Street 2, Modi’in 7177871, Israel
    USA Phone: +1.785.856.0417 | Main Office: +972.77.212.3272

    info@revitalvision.com
    Contact background
    Start the Program